Opinion on Healthcare in United States

Published within

« | 1 | 2 | 3 | 4 | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Beth Israel: big pharma deal wanted

Published By Datamonitor
16 Feb 2001
CommentWire
CommentWire

Centocor: ambulance delivery to revive clot-buster sales

Pre-hospital thrombolysis should revitalize sales of thrombolytics, which have seen falling sales since 1998 because PCTA and stenting are more effective. However, the new procedure may be slow to reach the US, because of the high risk of litigation. And even where pre-hospital thrombolysis does take off, the major beneficiary will be Genentech's TNKase.

Published By Datamonitor
04 Jul 2002
Expert View
Expert View

Challenging times ahead for US pharma

President Obama's winning of a second term in office places further pressure on the pharma industry, with a more aggressive stance expected towards limiting drug expenditure. However, while the industry may well have fared better under challenger Romney, pharma faced hard times regardless of the outcome of the election.

Published By Datamonitor
09 Nov 2012
CommentWire
CommentWire

eProcurement: Medical Columbus may suffer in the New World

Published By Datamonitor
27 Oct 2000
CommentWire
CommentWire

FirstHealth: paying doctors for web visits

Published By Datamonitor
23 Nov 2000
CommentWire
CommentWire

Food Sciences: opportunities in healthier living

New Direction is a behavioral change program that encourages people to exercise more and eat healthily. With obesity on the rise, demand for effective treatments is high. Systems such as New Direction are particularly important as currently marketed drugs have proved disappointing, and more promising agents will not hit the market for many years.

Published By Datamonitor
07 May 2002
CommentWire
CommentWire

GlaxoSmithKline: smoke blows both ways

A new study suggests that without physician support, OTC nicotine replacement drugs may be useless. This is interesting reading for GSK, which is the biggest producer of anti-smoking drugs. The news should boost prescription-only Zyban, but GSK may have to invest in physician support to maintain sales of NRT drugs Nicorette and NicoDerm.

Published By Datamonitor
12 Sep 2002
ResearchWire
ResearchWire

Healthcare IT: BI spend to rise as scope of usage grows

Published By Datamonitor
06 Jul 2007
Expert View
Expert View

Healthcare IT: driving US presidential campaigns

The three leaders in the race for the US presidency; Hilary Clinton, Barack Obama and John McCain, have all cited technology in their campaigns for healthcare reform. However, while IT may feature in the next president's healthcare agenda, doubt remains as to whether any of the candidates will deliver fully on their proposals.

Published By Datamonitor
12 Feb 2008
CommentWire
CommentWire

Heart failure: quality of care is a gamble in US hospitals

A study funded by Scios has found that four standard treatment measures key to treating heart failure are unwittingly withheld in a number of US hospitals. In order to address this issue, hospitals should look to improve educational programs for physicians, as well as considering an increase in the use of certain key cardiovascular drugs.

Published By Datamonitor
15 Jul 2005

« | 1 | 2 | 3 | 4 | » »|

No help is available.